The US-based technology company, Amazon, has received Food and Drug Administration (FDA) approval for its COVID-19 testing by its subsidiary STS Lab Holdco and the company now intends to use it for its employee testing program.
According to The Verge, Amazon Company, which has a green flag from the FDA with its COVID-19 testing kit is now planning to use it for its existing Covid testing programs.
The test is performed using a nasal self swab which should be performed under the supervision of a medical service provider or as part of a home appliance where the patient can take his or her sample and send it to a combined laboratory.
FDA approval, obtained by The Verge reads, “Amazon plans to use the Amazon Real-Time RT-PCR Test for SARS-CoV-2 (Amazon Test) as part of the overall corporation for Coronavirus Disease 2019 (COVID- 19) and a response system. ”
“Amazon has partnered with a third-party healthcare provider that will issue the required orders and individualized testing instructions,” the authorization added.
In October, the organization said it had a basis for conducting a series of tests for its employees on a daily basis.
The new trial is an adaptation of another COVID-19 trial conducted by BGI Genomics, which authorized Amazon for use at the end of August.
The Verge indicated that the organization began implementing a modified version that would turn into an Amazon test on August 28, 2020. In mid-September and early December 2020, it ran more than 560,000 samples, according to approval.
Amazon began selling COVID-19 home test packages developed by genomics organization DxTerity in January. That trial sells for USD 110. The organization continues to receive health care: last week, it announced that it would begin offering its in-house telehealth program and home medical services to various organizations.
Amazon has also expressed interest in previous clinical trials. The Verge reported that back in 2018, the organization was in talks with the purchasing diagnostic agency Confer Health.